Insights

Expanding Medical Portfolio Avicanna's extensive product portfolio including medical cannabis, topical, transdermal, and proprietary formulations like RHO Phyto presents significant cross-selling opportunities to healthcare providers and pharmacies seeking diversified cannabinoid-based solutions.

International Market Growth The company's ongoing expansion into new international markets offers pathways to establish regional partnerships and distribution channels, especially in Latin American countries where their pharmaceutical products like Trunerox™ are already registered.

Strategic Collaborations Partnerships with major players like Philip Morris International and Vectura Fertin Pharma enhance Avicanna's market credibility and open doors for joint ventures, licensing deals, and co-marketing opportunities to accelerate product adoption.

Clinical Development Pipeline Avicanna's pipeline of indication-specific, patent-pending drug candidates targeting dermatology, pain management, and neurological conditions presents opportunities for healthcare providers and clinics to adopt innovative therapeutics in underserved areas.

Educational Engagement Collaborations with healthcare associations and the launch of patient support platforms like MyMedi.ca create avenues for engaging medical professionals and patients, fostering trust and driving adoption of personalized cannabis-based treatment regimens.

Similar companies to Avicanna Inc. (TSX:AVCN)

Avicanna Inc. (TSX:AVCN) Tech Stack

Avicanna Inc. (TSX:AVCN) uses 8 technology products and services including Vue.js, jQuery Migrate, Salesforce Marketing Cloud, and more. Explore Avicanna Inc. (TSX:AVCN)'s tech stack below.

  • Vue.js
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Salesforce Marketing Cloud
    Marketing Performance Measurement
  • Bootstrap
    UI Frameworks
  • YouTube
    Video Players
  • MailChimp for WordPress
    Web Platform Extensions
  • Apache
    Web Servers
  • bxSlider
    Web Tools And Plugins

Media & News

Avicanna Inc. (TSX:AVCN)'s Email Address Formats

Avicanna Inc. (TSX:AVCN) uses at least 1 format(s):
Avicanna Inc. (TSX:AVCN) Email FormatsExamplePercentage
First.Last@avicanna.comJohn.Doe@avicanna.com
87%
First.Middle@avicanna.comJohn.Michael@avicanna.com
10%
FirstMiddle.Last@avicanna.comJohnMichael.Doe@avicanna.com
2%
FL@avicanna.comJD@avicanna.com
1%

Frequently Asked Questions

Where is Avicanna Inc. (TSX:AVCN)'s headquarters located?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s main headquarters is located at 661 University Avenue 1300 Toronto, Ontario m5g 0b7 Canada. The company has employees across 4 continents, including North AmericaSouth AmericaEurope.

What is Avicanna Inc. (TSX:AVCN)'s official website and social media links?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s official website is avicanna.com and has social profiles on LinkedInCrunchbase.

What is Avicanna Inc. (TSX:AVCN)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Avicanna Inc. (TSX:AVCN) have currently?

Minus sign iconPlus sign icon
As of February 2026, Avicanna Inc. (TSX:AVCN) has approximately 73 employees across 4 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Executive Officer: A. A.Vice President - Operations: T. W.Vice President Commercial Operations Europe / Latam: J. K.. Explore Avicanna Inc. (TSX:AVCN)'s employee directory with LeadIQ.

What industry does Avicanna Inc. (TSX:AVCN) belong to?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN) operates in the Biotechnology Research industry.

What technology does Avicanna Inc. (TSX:AVCN) use?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s tech stack includes Vue.jsjQuery MigrateSalesforce Marketing CloudBootstrapYouTubeMailChimp for WordPressApachebxSlider.

What is Avicanna Inc. (TSX:AVCN)'s email format?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)'s email format typically follows the pattern of First.Last@avicanna.com. Find more Avicanna Inc. (TSX:AVCN) email formats with LeadIQ.

How much funding has Avicanna Inc. (TSX:AVCN) raised to date?

Minus sign iconPlus sign icon
As of February 2026, Avicanna Inc. (TSX:AVCN) has raised $2.1M in funding. The last funding round occurred on Aug 01, 2021 for $2.1M.

When was Avicanna Inc. (TSX:AVCN) founded?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN) was founded in 2016.

Avicanna Inc. (TSX:AVCN)

Biotechnology ResearchOntario, Canada51-200 Employees

Avicanna is a life sciences company focused on advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D & clinical development that has led to the commercialization of 30+ products across various market segments: 

•	Medical Cannabis & Wellness Products (RHO Phyto™): The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, & transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto is a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets.

•	Pharmaceutical Preparations and Pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has an extensive pipeline of indication-specific, patent-pending drug candidates in various stages of clinical development and commercialization. These drug candidates aim to address unmet medical needs in dermatology, chronic pain, and various neurological disorders. Avicanna’s first pharmaceutical preparation (Trunerox™) is approved in Colombia and is in registration in other South American markets.

•	MyMedi.ca Medical Cannabis Care: MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc., and features a diverse portfolio of products and pharmacist-led patient support programs. It also provides specialty services to distinct patient groups such as veterans and collaborates with public and private providers for adjudication and reimbursement. MyMedi.ca provides educational resources to facilitate the incorporation of medical cannabis into health care regimens.

Section iconCompany Overview

Headquarters
661 University Avenue 1300 Toronto, Ontario m5g 0b7 Canada
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $2.1M

    Avicanna Inc. (TSX:AVCN) has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.1Mas a secured term loan financing.

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $2.1M

    Avicanna Inc. (TSX:AVCN) has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.1Mas a secured term loan financing.

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.